Cargando…

Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance

In 2009, a list of nonpolymorphic HIV-1 drug resistance mutations (DRMs), called surveillance DRMs (SDRMs), was created to monitor transmitted drug resistance (TDR). Since 2009, TDR increased and antiretroviral therapy (ART) practices changed. We examined the changing prevalence of SDRMs and identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rhee, Soo-Yon, Tzou, Philip L., Shafer, Robert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150354/ https://www.ncbi.nlm.nih.gov/pubmed/34064774 http://dx.doi.org/10.3390/v13050879

Ejemplares similares

HIV‐1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates
por: Rhee, Soo‐Yon, et al.
Publicado: (2020)

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
por: Bennett, Diane E., et al.
Publicado: (2009)

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis
por: Avila-Rios, Santiago, et al.
Publicado: (2016)

Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance
por: Rhee, Soo-Yon, et al.
Publicado: (2023)

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance
por: Gifford, Robert J., et al.
Publicado: (2009)

HIV-1 5’-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance Mutations
por: Nouhin, Janin, et al.
Publicado: (2023)

Genetic Variability of HIV-1 for Drug Resistance Assay Development
por: Clutter, Dana S., et al.
Publicado: (2016)

Selection analyses of paired HIV-1 gag and gp41 sequences obtained before and after antiretroviral therapy
por: Tzou, Philip L., et al.
Publicado: (2018)

Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
por: Reuman, Elizabeth C., et al.
Publicado: (2010)

HIV-1 Group M Capsid Amino Acid Variability: Implications for Sequence Quality Control of Genotypic Resistance Testing
por: Tao, Kaiming, et al.
Publicado: (2023)

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population
por: Rhee, Soo-Yon, et al.
Publicado: (2019)

Time trends in HIV-1 transmitted drug resistance mutation frequency in Poland
por: Parczewski, Milosz, et al.
Publicado: (2014)

More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
por: Feder, Alison F, et al.
Publicado: (2016)

Correction: More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
por: Feder, Alison F, et al.
Publicado: (2017)

Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review
por: Rhee, Soo-Yon, et al.
Publicado: (2022)

Geographically-stratified HIV-1 group M pol subtype and circulating recombinant form sequences
por: Rhee, Soo-Yon, et al.
Publicado: (2018)

Response to Therapy in Antiretroviral Therapy–Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor–Associated Transmitted Drug Resistance
por: Clutter, Dana S., et al.
Publicado: (2016)

Persistence of HIV-1 Transmitted Drug Resistance Mutations
por: Castro, Hannah, et al.
Publicado: (2013)

Sentinel Surveillance of HIV-1 Transmitted Drug Resistance, Acute Infection and Recent Infection
por: Truong, Hong-Ha M., et al.
Publicado: (2011)

A systematic review of the genetic mechanisms of dolutegravir resistance
por: Rhee, Soo-Yon, et al.
Publicado: (2019)

HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
por: Blanco, Jose-Luis, et al.
Publicado: (2011)

Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
por: Rhee, Soo-Yon, et al.
Publicado: (2015)

Correction: Sentinel Surveillance of HIV-1 Transmitted Drug Resistance, Acute Infection and Recent Infection
por: Truong, Hong-Ha M., et al.
Publicado: (2011)

Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
por: Rhee, Soo-Yon, et al.
Publicado: (2015)

National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico
por: Avila-Ríos, Santiago, et al.
Publicado: (2011)

Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review
por: Tao, Kaiming, et al.
Publicado: (2023)

Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations
por: Vega, Yolanda, et al.
Publicado: (2015)

Statewide Longitudinal Trends in Transmitted HIV-1 Drug Resistance in Rhode Island, USA
por: Novitsky, Vlad, et al.
Publicado: (2021)

Correction: National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico
por: Avila-Ríos, Santiago, et al.
Publicado: (2012)

Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom
por: Tostevin, A, et al.
Publicado: (2016)

Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients
por: Kapoor, Amit, et al.
Publicado: (2008)

HIV-1 Subtype B Protease and Reverse Transcriptase Amino Acid Covariation
por: Rhee, Soo-Yon, et al.
Publicado: (2007)

A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes
por: Doherty, Kathleen M, et al.
Publicado: (2011)

Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999–2018
por: Ismael, Nalia, et al.
Publicado: (2022)

1525. Evolving Trends in HIV Transmitted Drug Resistance in Eastern North Carolina
por: Reddy, Srinivas, et al.
Publicado: (2023)

Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil
por: Bahls, Larissa Danielle, et al.
Publicado: (2019)

Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences
por: Tzou, Philip L., et al.
Publicado: (2020)

Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds
por: Tzou, Philip L., et al.
Publicado: (2020)

Estimation of the HIV-1 backward mutation rate from transmitted drug-resistant strains
por: Kitayimbwa, J.M., et al.
Publicado: (2016)

Surveillance of transmitted HIV-1 antiretroviral drug resistance in the context of decentralized HIV care in Senegal and the Ebola outbreak in Guinea
por: Mbange, Aristid Ekollo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_54cle0ntg6tagpmkpmfol97quo